| Previous Close | 128.9100 |
| Open | 129.0600 |
| Bid | 128.9500 x 200 |
| Ask | 128.9500 x 200 |
| Day's Range | 128.8500 - 129.1000 |
| 52 Week Range | 106.6900 - 129.1000 |
| Volume | 285,061 |
| Avg. Volume | 1,877,884 |
| Net Assets | 603.53B |
| NAV | 126.96 |
| PE Ratio (TTM) | N/A |
| Yield | 1.88% |
| YTD Return | 11.12% |
| Beta (3y) | 1.01 |
| Expense Ratio (net) | 0.04% |
| Inception Date | 2001-05-24 |
- Market Realist•4 days ago
Abbott Gets UK Reimbursement Approval for Freestyle Libre
On September 13, 2017, Abbott Laboratories (ABT) announced the reimbursement approval of its Freestyle Libre system.
- Market Realist•4 days ago
Label Expansion in Asthma Indication May Boost Dupixent’s Sales
Dupixent combined with standard of care also showed 12%–15% improvement in FEV1 from baseline in asthma patients after 12 weeks of treatment compared to those treated with standard of care alone.
- ETF Trends•5 days ago
10 Super-Cheap Vanguard ETFs for Investors
ETF adoption has rapidly accelerated in recent years, with many investors steering to cheap ETFs to potentially bolster long-term investment returns. There are 2,040 U.S.-listed ETFs on the market with ...
